Skip to main content

DarioHealth Corp

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Interim Consolidated Statements of Comprehensive Loss

​​​​​​​​​​​​​
​ · ​ · Three months ended · ​ · Nine months ended
​ · ​ · September 30, · ​ · September 30,
​ · 2024 · 2023 · 2024 · 2023
​​Unaudited​Unaudited
Revenues:​​​​​​​​​​​​
Services​$5,604​$1,765​$14,424​$11,171
Consumer hardware​​1,819​​1,753​​5,012​​5,565
Total revenues​​7,423​​3,518​​19,436​​16,736
​​​​​​​​​​​​​
Cost of revenues:​​​​​​​​​​​​
Services​​920​​599​​2,845​​3,701
Consumer hardware​​1,282​​1,203​​3,786​​3,902
Amortization of acquired intangible assets​​1,344​​1,106​​3,740​​3,281
Total cost of revenues​3,546​2,908​10,371​10,884
​​​​​​​​​​​​​
Gross profit​3,877​610​9,065​5,852
​​​​​​​​​​​​​
Operating expenses:​​​​​​​​
Research and development​$5,446​$5,665​$18,898​$16,052
Sales and marketing​6,733​6,363​20,775​19,163
General and administrative​3,728​4,128​15,468​12,611
​​​​​​​​​​​​​
Total operating expenses​15,907​16,156​55,141​47,826
​​​​​​​​​​​​​
Operating loss​12,030​15,546​46,076​41,974
​​​​​​​​​​​​​
Total financial expenses (income), net​313​186​(10,954)​3,168
​​​​​​​​​​​​​
Loss before taxes​​12,343​​15,732​​35,122​​45,142
​​​​​​​​​​​​​
Income Tax​​13​​—​​2,007​​—
​​​​​​​​​​​​​
Net loss​$12,330​$15,732​$33,115​$45,142
​​​​​​​​​​​​​
Other comprehensive loss:​​​​​​​​​​​​
Deemed dividend (contribution)​$2,278​$1,172​$(4,394)​$2,863
​​​​​​​​​​​​​
Net loss attributable to common shareholders​$14,608​$16,904​$28,721​$48,005
​​​​​​​​​​​​​
Net loss per share:​​​​​​​​
​​​​​​​​​​​​​
Basic and diluted loss per share of common stock​$0.25​$0.49​$0.52​$1.52
Weighted average number of common stock used in computing basic and diluted net loss per share​40,417,421​28,815,604​39,093,575​28,195,216

INTERIM STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.